SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.25p
   
  • Change Today:
    -0.50p
  • 52 Week High: 29.00
  • 52 Week Low: 7.25
  • Currency: UK Pounds
  • Shares Issued: 200.38m
  • Volume: 58,268
  • Market Cap: £18.54m

Latest ShareCast News

SkinBioTherapeutics reports positive interim acne study findings

By Josh White

Date: Tuesday 27 Feb 2024

(Sharecast News) - Life science company SkinBioTherapeutics reported encouraging interim findings from its ongoing AxisBiotix acne food supplement study featuring its lead formulation on Tuesday.

SkinBioTherapeutics finalises acquisition of Dermatronics

By Josh White

Date: Friday 26 Jan 2024

(Sharecast News) - SkinBioTherapeutics announced on Friday that it has finalised the acquisition of Dermatonics, known for its topical and dermatological products within the skincare and wound care sector.

SkinBioTherapeutics launches new consumer study into acne

By Iain Gilbert

Date: Wednesday 25 Oct 2023

(Sharecast News) - Life sciences company SkinBioTherapeutics said on Wednesday that it had begun a new consumer study into acne, with two new formulas set to be trialled in order to compare efficacy against "the most common skin condition".

SkinBioTherapeutics gets France approval for pso... 15-Sep-2023 ShareCast
SkinBioTherapeutics selects probiotic blends for... 05-Sep-2023 ShareCast
SkinBioTherapeutics launching psoriasis suppleme... 21-Jun-2023 ShareCast
SkinBioTherapeutics pleased with progress on two... 10-May-2023 ShareCast
SkinBioTherapeutics reports progress with psoria... 17-Feb-2022 ShareCast
SkinBioTherapeutics commercially launches psoria... 29-Oct-2021 ShareCast
SkinBioTherapeutics confirms launch plans for ps... 30-Sep-2021 ShareCast
SkinBioTherapeutics launches research programme ... 08-Apr-2021 ShareCast
SkinBioTherapeutics confident in timelines amid ... 07-Jul-2020 ShareCast
SkinBioTherapeutics to develop psoriasis supplem... 19-Feb-2020 ShareCast
SkinBioTherapeutics strikes deal with chemicals ... 20-Nov-2019 ShareCast
SkinBioTherapeutics shuffles leadership as it dr... 04-Jul-2019 ShareCast
SkinBioTherapeutics pleased with first human stu... 08-Apr-2019 ShareCast
SkinBio seeking 'commercially experienced' CEO a... 14-Feb-2019 ShareCast
Skinbio begins human studies of moisturising cream 25-Oct-2018 ShareCast
SkinBioTherapeutics begins human study on SkinBi... 19-Sep-2018 ShareCast
SkinBioTherapeutics to begin human study this mo... 03-Sep-2018 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 9.25p
Change Today -0.50p
% Change -5.13 %
52 Week High 29.00
52 Week Low 7.25
Volume 58,268
Shares Issued 200.38m
Market Cap £18.54m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.01% below the market average70.01% below the market average70.01% below the market average70.01% below the market average70.01% below the market average
77.36% below the sector average77.36% below the sector average77.36% below the sector average77.36% below the sector average77.36% below the sector average
Price Trend
82.69% below the market average82.69% below the market average82.69% below the market average82.69% below the market average82.69% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Income Not Available
Growth
18.01% above the market average18.01% above the market average18.01% above the market average18.01% above the market average18.01% above the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average

SBTX Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
15:26 500 @ 9.06p
15:26 500 @ 9.06p
13:15 7,362 @ 9.44p
11:41 4,075 @ 9.06p
11:00 190 @ 9.50p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page